Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Colorectal cancer statistics, 2023
2023 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Management of hepatitis B
2007
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients
2007
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
2016
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
2008
Molecular diagnosis and treatment of drug-resistant hepatitis B virus
2014
Global epidemiology and genotype distribution of the hepatitis C virus infection
2014
Tenofovir plus lamivudine as rescue therapy for adefovir‐resistant chronic hepatitis B in hepatitis B e antigen‐positive patients with liver cirrhosis
2008
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance
2007
A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect?
2007
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota
2002
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
1996
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Antiviral drug-resistant HBV
2007
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Hepatitis B virus infection
2009 Standout
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists
2015
Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients
2007
Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases
2017
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
2006
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
2014
Colorectal cancer
2019 Standout
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
2016
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination
2015
Treating viral hepatitis C: efficacy, side effects, and complications
2006
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
2013
Management of treatment failure in chronic hepatitis B
2012
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Review article: current antiviral therapy of chronic hepatitis B
2008
Chronic hepatitis B
2007 Standout
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus strains #
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
High Prevalence of Anti-HCV Antibodies in Two Metropolitan Emergency Departments in Germany: A Prospective Screening Analysis of 28,809 Patients
2012
Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose
2010
Gut flora in health and disease
2003 Standout
Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon
2012
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure
2016
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial
2011
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Polypectomy Rate: A Surrogate for Adenoma Detection Rate Varies by Colon Segment, Gender, and Endoscopist
2013
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B
2012
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Inflammatory bowel disease and the risk of fracture
2003
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Design of therapeutic vaccines: hepatitis B as an example
2011
Review article: chronic hepatitis B – anti‐viral or immunomodulatory therapy?
2010
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Tenofovir Improves the Outcome in Patients with Spontaneous Reactivation of Hepatitis B Presenting as Acute-On-Chronic Liver Failure §Δ
2010
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Management of Crohn's Disease in Adults
2009 Standout
Entecavir therapy for lamivudine‐refractory chronic hepatitis B
2008
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
2015
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
2011
Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years
2016
Screening for Colorectal Cancer
2021
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Screening for Thyroid Cancer
2017
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
2013
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
2010
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
2014
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Screening for Colorectal Cancer
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Suboptimal Response to Adefovir Dipivoxil Therapy for Chronic Hepatitis B in Nucleoside-Naive Patients is not due to Pre-Existing Drug-Resistant Mutants
2008
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
2015
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals
2013 StandoutNobel
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
2014 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Quality indicators for colonoscopy
2014 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
2017
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
1997
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
2012
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Sexual Function and Body Image are Similar after Laparoscopy‐Assisted and Open Ileal Pouch–Anal Anastomosis
2014
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
2010
Works of D Hüppe being referenced
Diagnostische Bedeutung und Akzeptanz der Vorsorgekoloskopie - erste Ergebnisse
2004
Therapie der chronischen Hepatitis C mit PEG-Interferon alpha-2b und Ribavirin: 24 Wochen Behandlung sind ausreichend bei HCV-Genotyp 2 und 3
2003
Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: An online IBD registry
2012
Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269 000 cases
2009
Evaluation of Different Laboratory Tests and Activity Indices Reflecting the Inflammatory Activity of Crohn's Disease
1992
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
2006
Die Vorsorgekoloskopie rettet Leben - Ergebnisse der Herner Vorsorgedatei
2008
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
2009
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
2000
Treatment Results of Chronic Hepatitis C Genotype 5 and 6 Infections in Germany
2012
IBD ahead 2010 – Antworten auf zehn zentrale Fragen in der aktuellen Therapie des Morbus Crohn
2011
[Effect of chronic alcohol drinking and liver cirrhosis on oro-cecal transit time (H2 breath test)].
1989
[Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography].
1994
[Orthograde intestinal irrigation with a mannitol solution in reducing hepatic encephalopathy in patients with liver cirrhosis and gastrointestinal hemorrhage].
1989
Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C
2015
Epidemiologie der chronischen Hepatitis C in Deutschland - Eine Analyse von 10 326 Hepatitis-C-Virus-Infizierten aus Schwerpunktpraxen und -ambulanzen
2008
Evolution of Adefovir-Resistant HBV Polymerase Gene Variants after Switching to Tenofovir Disoproxil Fumarate Monotherapy
2012